How to Buy Engene Therapeutics Stock

Engene Therapeutics Inc

enGene Holdings Inc. , through its subsidiary enGene, Inc. , operates as a clinical-stage biotechnology company that develops genetic medicines through the delivery of therapeutics to mucosal tissues and other organs.

Engene Therapeutics stock last closed at $6.96, down 3.33% from the previous day, and has increased 74.44% in one year. It has overperformed other stocks in the Biotechnology industry by 0.85 percentage points. Engene Therapeutics stock is currently +162.64% from its 52-week low of $2.65, and -43.18% from its 52-week high of $12.25.

There are currently 66.99M shares of ENGN outstanding. The market capitalization of ENGN is $466.25M. In the last 24 hours, 1.78M ENGN shares were traded.

How to Buy Engene Therapeutics Stock

Wondering how to invest in Engene Therapeutics stock? Here's how.

  1. Choose where to buy Engene Therapeutics stock: You need to decide on a stock brokerage, but don't worry - we've researched dozens of stock brokerages and apps to help you decide where to buy Engene Therapeutics stock.
  2. Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
  3. Put funds into your investment account: Pick your payment method and add your info.
  4. Research Engene Therapeutics stock: The Engene Therapeutics ticker symbol is ENGN. Is Engene Therapeutics stock a good investment? Should you buy shares of ENGN? How do ENGN's underlying business fundamentals look? Do top analysts think Engene Therapeutics is a good buy? Why has ENGN's stock price moved recently? (Hint: Our stock research website can help you understand if ENGN is a good stock to buy).
  5. Make your ENGN purchase: Decide if you will purchase ENGN shares at the current market price or use a limit order to buy ENGN shares at a given price.
  6. Watch your ENGN investment: Create a watchlist to the latest updates on your new investment in Engene Therapeutics stock.

Step 1: Choose where to buy Engene Therapeutics stock

You need a brokerage account in order to access the NASDAQ market and buy ENGN shares.

A brokerage account allows you to buy and sell a variety of financial instruments, such as stocks, bonds, mutual funds, and ETFs.

Our favorite brokerage: eToro

Based on our experience, eToro is the best place to buy stocks. Here's why:

  • Invest in stocks with 0% commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
  • Access to global markets: From Technology to Financial Services, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top stock exchanges.
  • Social investing: eToro boasts a community of more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of other investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other assets: Such as ETFs and cryptocurrencies.

Get $10 towards your purchase of shares by opening an account with eToro now. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Create a brokerage account

Now that you've selected the best brokerage, you'll need to fill out some personal information so you are able to invest in ENGN stock today.

How to Start a New Brokerage Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Provide your personal data to create a new brokerage account.
  1. Send your data by hitting the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Put funds into your investment account

Now that you've opened your account on the best stock buying app, you need to deposit funds:

Check out the walkthrough below if you need help depositing money into your investment account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Research Engene Therapeutics stock

After you have identified the best place to buy Engene Therapeutics stock, it's crucial to analyze their stock prior to buying, so you actually understand the risk as well as the upside.

Engene Therapeutics shares quick numbers

ENGN Price
$6.96
1w %
-18.21%
1y %
74.44%
5y %
N/A
P/E
-3.09x
P/B
1.66x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$122.44M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$466.25M
Next Earnings
N/A
Next Dividend
N/A

Fundamentals of ENGN

WallStreetZen was designed to help everyday investors do better fundamental analysis quickly.

You can view all of the due diligence checks on ENGN's stock page.

Is ENGN stock properly valued?

Analysts use a variety of different financial metrics, analyses, models, and charts to gauge ENGN's intrinsic value.

Using relative valuations methods:

  • ENGN may be undervalued based on its P/B ratio of 1.66x, relative to Biotechnology industry P/B ratio of 4.88x

You can access more valuation research on ENGN's stock here.

ENGN Financial Health Overview

Positive Health Checks:

  • ENGN has a low debt to equity ratio of 0.2.
  • ENGN has cash burn of 103785000. It has enough cash and short-term investments to cover this for at least one year.
  • There are more short-term assets than short-term liabilities on the ENGN balance sheet.
  • There are more short-term assets than long-term liabilities on the ENGN balance sheet.
  • ENGN has $276.02M in cash and short term investments. This is enough to cover its annual cash burn of $103.79M.

Do Wall Street analysts think it's a good time to buy ENGN stock

Out of 6 Wall Street analysts who monitor ENGN, the consensus analyst rating on Engene Therapeutics is a Buy

It's important to note that analyst forecasts are not stock recommendations, nor are they financial advice.

Most Recent ENGN Analyst Forecasts

Silvan Tuerkcan, a top 6% analyst from Citizens maintains ENGN with a buy rating and raises their ENGN price target from $18.00 to $21.00, on Nov 12, 2025.

You can dig deeper into what analysts are saying on the Engene Therapeutics stock forecast page.

ENGN Technical Indicators

SMA10
7.98
SMA20
7.57
SMA50
8.02
SMA100
8.59
SMA200
7.31
MACD
0.01
MACD Signal
0.02
MACD Histogram
-0.02
RSI
38.36
Stochastic %K
23.62
Stochastic %D
46.16
StochRSI %K
13.68
StochRSI %D
37.13

Who is buying/selling ENGN?

Over the past year, insiders at ENGN have not bought or sold any shares.

Dig into more about who owns ENGN shares here.

Does ENGN provide a stable income stream?

No, Engene Therapeutics doesn't provide an income stream by paying out dividends.

What others are saying about ENGN

One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.

Click below to see what other investors have to say.

Step 5: Make your ENGN purchase

You have two main order types:

  • Market order: A market order is an order to buy or sell a stock at the best price on the market.
    Market orders are mostly sufficient.
  • Limit order: A limit order allows you to buy or sell a security at a specific price (or better).
    If you want to ensure you're buying or selling at a specific dollar amount limit, place a limit order.

Click the Open button and eToro will execute the order.

If you need additional info about buying stocks on eToro, watch the helpful video below:

Open eToro Account

Step 6: Watch your ENGN investment

Now that you own some shares in ENGN, you'll want to stay up-to-date on your new company.

Create a watchlist to get notified of important updates regarding your ENGN stock.

ENGN Feed

How to Buy Stock in Engene Therapeutics

To reiterate, here are the 6 steps for buying Engene Therapeutics stock:

  1. Choose where to buy Engene Therapeutics stock
  2. Create a brokerage account
  3. Put funds into your investment account
  4. Research Engene Therapeutics stock
  5. Make your ENGN purchase
  6. Watch your ENGN investment

If you are looking for a online brokerage, eToro is our recommended venue.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to get the latest scoop on your investment in Engene Therapeutics, add ENGN to your watchlist below.

NASDAQ: ENGN
$6.96-0.24 (-3.33%)
Updated Apr 28, 2026
Open eToro Account
Your capital is at risk.
NASDAQ: ENGN
$6.96-0.24 (-3.33%)
Updated Apr 28, 2026
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Engene Therapeutics share?

As of Apr 28, 2026, it costs $6.96 to buy one share of Engene Therapeutics stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $3, you can buy 0.431 shares of ENGN.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Engene Therapeutics stock?

According to 6 Wall Street analysts who monitor Engene Therapeutics, their consensus recommendation is to buy Engene Therapeutics stock.

What is the best way to buy Engene Therapeutics stock?

One way to place an order for Engene Therapeutics stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.